Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$1.95 - $2.54 $17,602 - $22,928
-9,027 Reduced 38.94%
14,157 $31,000
Q4 2022

Feb 13, 2023

BUY
$1.97 - $2.66 $45,672 - $61,669
23,184 New
23,184 $48,000
Q3 2021

Nov 15, 2021

SELL
$3.4 - $4.24 $51,761 - $64,549
-15,224 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$3.76 - $5.14 $57,242 - $78,251
15,224 New
15,224 $65,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $101M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.